most common infectious cause of congenital disease and a serious complication in immunocompromised hosts. Quantitative analysis of polyamine biosynthesis in human diploid fibroblasts (MRC-5 cells) infected with human CMV showed that the intracellular levels of spermidlne and spermine were 1.5-and 12.4-fold hi her, respectively, than requirement for continued polyamine biosynthesis during human CMV replication was demonstrated by the antiviral effects of, MGBG and DFMO using plaque reduction methods. An ED,, value of 0 . 6~~ for MGBG compares with values of 33.5 PM for 9-(2-hydroxyethoxymethyl)-guanine and 5.3 PM for 5-iodo-2'-deoxyuridine : both nucleoside analogues have been used clinically for the treatment of human CMV infections. Although MGBG has additional effects on cell functions other than polyamine metabolism, the anti-viral effect is not due to indiscriminate toxic action on the host cells since vaccinia virus is able' to replicate in MRC-5 cells treated with MGBG at concentrations which completely inhibit human CMV replication (Tyms et al., 1983) . Because DFMO is catalytically activated by ornithine decarboxylase to irreversibly inhibit the enzyme, this unique action confers high specificity. There was a marked reduction in the amount of infective virus produced in MRC-5 cells treated with IOmM-DFMO that was accompanied by a complete inhibition of the formation of intranuclear inclusions, which are the sites of virus-specific DNA synthesis in human CMV-infected cells (Tyms & Williamson, 1982) . The anti-viral effect of DFMO against human CMV replication has been confirmed in a recent study with human foreskin fibroblast cells but their exposure to the drug for 3 days before infection was required to obtain the maximum reduction in virus yield and postreplicative events in the virus-replication cycle appeared to be affected (Gibson et al., 1984) . Pretreatment with DFMO or MGBG is also necessary to inhibit herpes simplex virus replication (Tuomi et al., 1980; Tyms et al., 1983) . Both inhibitors of polyamine metabolism have recently been used in uninfected control cells (Tyms & 8, illiamson, 1982 The herbicide paraquat ( I , I'-dimethyl-4,4'-bipyridylium) has been marketed throughout the world for approximately 20 years. Although it has proved remarkably safe in use (Swann, 1969; Howard et al., 1981) there have been, during the last two decades, several hundred human fatalities attributed to paraquat poisoning. These have largely been a consequence of the intentional ingestion of the concentrated commercial product for suicidal purpose (Fletcher, 1974) .
When paraquat is swallowed the symptoms of poisoning depend largely on the amount consumed. However, by far the most characteristic feature of paraquat poisoning is damage to the lung which, if extensive enough, will lead to death due to anoxia. The mechanism by which paraquat damages the lung has been studied most extensively in the rat. Paraquat is not metabolized in experimental animals and Sharp et al. (1972) first demonstrated that the lungs of rats intravenously dosed with paraquat had the highest concentration and selectively retained the compound in comparison with other organs. After the oral administration of paraquat to rats, the concentration in the plasma remains relatively constant over a period of 30h, whereas that in the lung increases with time such that by 30h after dosing there is 6-7 times more in the lung than in the plasma . Thus, after oral dosing the lung, which is the organ most severely damaged by paraquat, has the ability to accumulate the compound to several times the concentration found in the plasma and retains paraquat independent of the fall in plasma concentration (Sharp et a[., 1972) . This selective accumulation/retention in the lung provides a convincing explanation why this organ is selectively damaged by paraquat after oral or parenteral administration. In man the major organs affected are the lung and kidney. It therefore seems likely that paraquat is selectively accumulated in the human lung and excreted by the kidney.
Accumulation of paraquat in the lung
In order to study this accumulation process further the uptake of "T-labelled paraquat into slices of rat lung was investigated. By using this technique a time-dependent accumulation into lung slices was established. This accumulation could be inhibited by the addition of cyanide or iodoacetate or when the incubation was carried out under nitrogen (Rose et al., 1974) . The uptake was also shown to be temperature dependent and it appears therefore that paraquat accumulation by slices of rat lung is dependent upon energy production (Rose et al., 1974) . The accumulation of paraquat into the lung cannot be explained as a 610th MEETING, STIRLING consequence of binding of paraquat to the tissue (Ilett et al., 1974; Rose & Smith, 1977~ ). It appears that the process is a consequence of the transport of paraquat into an intracellular compartment. The accumulation obeys saturation kinetics and it is possible to determine an apparent K , of 7 0 p~ and a V,,,. of 300nmol of paraquat/h per g of lung (Rose et al., 1974) . This accumulation process has been found to be confined to the lung and to a lesser extent the brain cortex (Rose et al., 1976) .
Accumulation of polyamines in the lung
The discovery that paraquat was accumulated by the lung led to the suggestion that its uptake is a consequence of it being mistaken for an endogenous compound(s) which is normally accumulated by the lung (Smith, 1982) . In order to investigate this hypothesis a number of compounds were tested for their ability to inhibit the accumulation of paraquat into the lung. Amongst the most effective inhibitors were a series of diamines and polyamines which included putrescine, spermidine and spermine. The diamine putrescine and the polyamines spermidine and spermine are themselves accumulated into the lung by a process which obeys saturation kinetics (Smith et al., 1983~) . The apparent K, and V,,,,,, values for the accumulation of these oligosamines are similar ( Table 1) and although the V,,,. for the uptake of paraquat is of the same order as that described for the oligosamines the K, is approx. ten-fold greater (Table I ). It seems reasonable to conclude that a single process is responsible for the accumulation of diamines and polyamines into the lung and that the reason why paraquat is accumulated by the lung is that it is transported by this process in mistake for these endogenous substrates. This diamine-and polyamine-accumulation process has been demonstrated in the lungs of several species of experimental animal (Smith et a/., 19836) and also in human lung (Brooke-Taylor et al.. 1983).
The most probable reason for the pulmonary uptake of paraquat is its structural similarity to the diamines and polyamines with respect to the separation of the quaternary nitrogen atoms of paraquat and the amino groups of the oligoamines. The structural requirements of this process have been characterized by Gordonsmith et a/. (1983) . These authors used the inhibition of putrescine accumulation into lung slices in the presence of various compounds to determine the structural requirements of compounds to inhibit pulmonary diamine accumulation. The presence of more than one amino group markedly increased the ability of compounds to block putrescine accumulation, as illustrated b y the diamino alkanes ( Table 2 ). The inhibitory potential of both the diamino alkanes and the monoamines increased with increasing chain length ( Table 2) . I t appears that a distance of four methylene units or approx. 0.62nm between the nitrogen atoms is required for a compound to be a good inhibitor of, and possibly a suitable substrate for, the pulmonary diamine and polyamine uptake system. The importance of the charge separation between the nitrogens can be seen in the case of the toxicology of diquat (1,l'-ethylene-2,2'-bipyridylium) which shares several of the Table 2 . Structural requirements of compounds to inhibit pulmonary diamine accumulation Slices of rat lung were incubated in Hanks balanced salt solution (Hanks & Wallace, 1949) or Krebs-Ringer phosphate with glucose medium (Krebs & Henseleit, 1932) (pH 7.4) containing putrescine (1 pM; 0.1 pCi/3 ml vol.). The 15, values were determined by the method of Ross & Krieger (1981) Table 3 . Structural requirements of compounds to inhibit pulmonary diamine accumulation Slices of rat lung were incubated in Hanks balanced salt solution (Hanks & Wallace, 1949) or in Krebs-Ringer phosphate with glucose medium (Krebs & Henseleit, 1932) (pH 7.4) containing 1 pM-putrescine (0.1 pCi/3ml vol.). The inhibitors were present at zero time and incubated either for 10,20 and 30min or for 5, 15 and 30min at 37°C in a shaking water bath. I,, values were determined by the method of Ross & Krieger (1981) , each animal acting as its own control. Results are expressed as meanSkS.E.M., at least three animals being employed per compound studied. Data are taken from Gordonsmith et al. (1983) . 
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NH+? ('00- physical and chemical properties of paraquat. Diquat is itself phytotoxic although its spectrum of herbicidal activity is not the same as that for paraquat. When diquat is given to rats at lethal doses it does not cause lung damage nor is it itself accumulated into the lung (Rose & Smith, 1977h) . The distance between the charges on the quaternary nitrogens of diquat is 0.34nm, which does not permit diquat to use the diamine-and polyamine-accumulation system. Thus, it is not concentrated in the lung in a similar manner to paraquat, thereby sparing the lung the characteristic toxicity associated with paraquat. The lack of inhibitory action of the amino acids ornithine or arginine indicates that the carboxy group adjacent to one of the cationic groups prevents the amino acid inhibiting the accumulation of oligoamines (Table 3 ). These amino acids in turn are therefore not accumulated by the oligoamine uptake process.
Cellular compartment for polyaniine accumulation
Definitive evidence for the cellular compartments into which paraquat is accumulated is not yet available. Waddell & Marlowe (1 980) concluded that paraquat was accumulated almost entirely into cells having the typical distribution of alveolar type I1 cells. There is also indirect evidence that paraquat and putrescine are accumulated into the same cell types (Smith & Wyatt, 1981) . In a series of yet unreported studies using autoradiographic techniques the distribution of paraquat, the diamine putrescine and the polyamine spermidine in lung slices has been found to be confined to the type I and type I1 cells and Clara cells of the lung (L. L. Smith & I. Wyatt, unpublished work) . However, from studies in vivo the distribution appears largely to be confined to the alveolar epithelium of the lung without Clara cell involvement (L. L. Smith & 1. Wyatt, unpublished work). This difference may reflect the non-physiological nature of tissue slice studies or may simply reflect the difficulties in maintaining high specific activities of the compound in studies in oivo compared with studies in uitro. In conclusion it appears from both indirect and direct evidence that the alveolar epithelium has at least in part a site for the accumulation of paraquat, the diamine putrescine and the polyamines spermidine and spermine.
Conclusions
After the discovery that the herbicide paraquat was accumulated into the lung, a search for endogenous compounds which could be natural substrates for this process led to the identification of several diamines and polyamines. The accumulation process is energy dependent and obeys saturation kinetics. The cellular compartment in the lung which accumulates these diamines and polyamines has been found to be at least in part the type I and type I1 alveolar epithelial cells. Although the biochemical or physiological significance of this process is not yet known its importance in the accumulation of the pulmonary toxicant paraquat has been established.
